Nevro Corp Virtual Investor Briefing At 2021 North American Neuromodulation Society (NANS) Virtual Conference Transcript
Good day, ladies and gentlemen, and welcome to the Nevro 2021 NANS Investor Briefing. (Operator Instructions) Please be advised that today's conference is being recorded. (Operator Instructions) I would now like to turn the call over to Julie Dewey. Please go ahead.
Good day, everyone. This is Julie Dewey, Nevro's Vice President of Investor Relations and Corporate Communications, and I'd like to welcome you to the Nevro 2021 NANS Investor Briefing. Here with me today are Keith Grossman, Nevro's Chairman, CEO and President; Dr. David Caraway, Nevro's Chief Medical Officer; and Rod MacLeod, Nevro's Chief Financial Officer.
Today's presentation slides are posted on our website at nevro.com in the Investors section, and we encourage you to download those slides or view via the webcast. Our speakers will refer to the slide numbers as they present so you can follow along during the presentation.
Moving to Slide 2. I'd like to review the agenda for today. First, Keith will provide
Access to All Earning Calls and Stock Analysis | |
30-Year Financial on one screen | |
All-in-one Stock Screener with unlimited filters | |
Customizable Stock Dashboard | |
Real Time Insider Trading Transactions | |
8,000+ Institutional investors’ 13F holdings | |
Powerful Excel Add-in and Google sheets Add-on | |
All data downloadable | |
Quick customer support | |
And much more... |